Table of Contents

Symbicort contains the inhaled steroid budesonide, and many people associate steroids with “moon-face,” puffiness, and belly fat.

While long-term medium or high-dose inhaled steroids can lead to small BMI increases, especially in women, research shows that breathing symptoms, poor sleep, flare-ups, and reduced activity often contribute even more to gradual weight gain.

Because these factors overlap, it can be hard to know whether changes come from Symbicort, your underlying condition, or unrelated lifestyle or hormonal shifts. In this guide, we’ll review what studies say about Symbicort and weight, how to identify what’s driving your weight changes, and how to protect your metabolic health while keeping your breathing well controlled.

Key Takeaways

  • Symbicort is not a common cause of noticeable weight gain, and short-term use is unlikely to change body weight.
  • Long-term medium or high-dose inhaled steroids may contribute to small yearly BMI increases in certain groups, but the effect is gradual and varies widely by dose, sex, and baseline weight.
  • Most weight changes seen while using Symbicort are usually caused by the asthma or COPD symptoms themselves. When breathing is harder, people naturally move less, and that decrease in daily activity can lead to gradual weight gain.
  • Sleep disturbances from uncontrolled respiratory symptoms can also indirectly increase weight by influencing appetite, energy levels, and abdominal fat accumulation over time.
  • Fluid retention and puffiness are typically not caused by Symbicort but may reflect changes from COPD progression or, in severe cases, strain on the right side of the heart.

Does Symbicort cause weight gain?

In clinical trials of Symbicort that led to its approval, common side effects included throat irritation, oral thrush, headache, and respiratory infections. Weight gain was not listed among the usual adverse events.

Early population studies did not show strong evidence that inhaled corticosteroids (ICS), which include Symbicort, alone caused overweight status compared with lifestyle factors.

More recent long-term studies, however, suggest that long-term medium or high-dose ICS may have systemic effects, including gradual weight gain. In one study, findings showed a dose-dependent pattern:

    • High-dose ICS users gained the most weight, with BMI rising an extra 0.25 kg/m² per year compared to the control group.
    • Medium-dose users also gained weight, though less (about 0.06 kg/m² per year).

In pediatric studies, children who used more ICS from ages 0 to 6 had slightly higher BMI scores at age 6 and a small trend toward higher abdominal fat percentage. They also experienced an earlier adiposity rebound, which can be a marker for future obesity risk.

Research also shows that men and women did not respond the same way. Women gained more weight when their ICS dose increased, while men showed slight weight loss as ICS doses increased.

Another large study analyzed weight and waist measurements from more than 81,000 adults over about 4 years. Local forms, like inhaled or intranasal steroids, were also linked to small yearly weight increases. Women and people who were already overweight or obese showed the clearest weight and waist increases.

But, short-term exposure appears to be safe.

A 2025 pilot study of adults taking high-dose ICS for 14 days showed no significant changes in weight, BMI, appetite, calorie intake, or leptin levels.

Does Symbicort cause belly fat or puffiness?

Man holding his belly

Symbicort is not known to cause belly fat or puffiness in most users. These effects are typically associated with oral corticosteroids, such as prednisone, which can increase appetite, cause fluid retention, and shift fat distribution.

These can cause changes like:

    • Round, puffy face, known as “moon face”
    • Increased fat around the neck and upper back (often called a “buffalo hump”)
    • Central weight gain (more fat around the abdomen, while arms and legs stay relatively thin)
    • Thinning skin that bruises easily
    • Purple stretch marks (striae), especially on the abdomen

Symbicort, on the other hand, contains an inhaled corticosteroid called budesonide. It is an anti-inflammatory medication that works primarily inside the lungs.

In addition, the liver rapidly breaks it down before it can enter the bloodstream in significant amounts. As a result, only a small fraction reaches the rest of the body, which helps limit systemic side effects.

Does Symbicort make you retain water?

Similar to belly fat and puffiness, Symbicort is not known for strong fluid retention effects. However, COPD may contribute to fluid retention. Here’s how:

1. CO2 retention & hormonal changes

In COPD, the lungs often struggle to remove carbon dioxide (CO2). When CO2 builds up, the body treats this as a stress signal. This triggers several hormone systems, which make the body act as if it’s dehydrated, causing it to hold onto water and salt, leading to swelling.

At the same time, CO2 build-up reduces blood flow to the kidneys, which further encourages the body to retain fluid because the kidneys think blood volume is too low.

2. Advanced COPD can lead to right-sided heart strain

Severe or long-standing COPD can raise pressure in the blood vessels of the lungs (pulmonary hypertension). The right side of the heart must pump against this high pressure, which eventually causes it to weaken. This condition is called cor pulmonale.

When the right heart can’t pump well, blood backs up into the veins. This leads to:

    • Swollen ankles and legs
    • Fluid in the abdomen
    • Weight gain from fluid retention

In simpler terms, the right heart gets overworked from lung disease and starts to fail, allowing fluid to pool in the body.

Other possible causes why you’re gaining weight while taking Symbicort

Often, multiple factors overlap. These include:

1. Asthma or COPD symptoms that limit activity

When breathing symptoms are not fully controlled, even small tasks can feel tiring. This can gradually reduce daily movement without you realizing it. For many people, this shows up as:

    • Getting short of breath during simple activities
    • Cutting back on walking, errands, or hobbies
    • Feeling less confident about exercise

These changes are completely understandable, especially when symptoms feel unpredictable or uncomfortable. But reduced movement also means fewer calories burned each day. Over months or years, that shift alone can lead to slow, steady weight gain even if your eating habits stay the same.

2. Poor sleep from nighttime symptoms

Nighttime coughing, wheezing, or waking to use a rescue inhaler disrupts sleep quality. One study followed 461 COPD patients for one year and found that nearly half (49.4%) of the patients had poor sleep quality at the start.

Poor sleepers were also less likely to improve and had a significantly higher risk of future flare-ups. In some groups, people with poor sleep had more flare-ups even when using triple therapy.

In addition, studies consistently show that chronic sleep loss is linked with:

    • Increased appetite
    • Higher weight
    • More abdominal fat

A study found that compared with average sleepers:

    • Short sleepers were 35% more likely to gain at least 5 kg.
    • Long sleepers were 25% more likely to gain at least 5 kg.

Over six years:

    • Short sleepers had a 27% higher risk of developing obesity.
    • Long sleepers had a 21% higher risk.

If Symbicort has not fully settled your nighttime symptoms yet, these sleep disruptions may be contributing to your weight changes.

3. Other medications you may be taking

Some medications commonly used alongside Symbicort can influence weight, including:

    • Oral corticosteroids for flare-ups
    • Antihistamines for allergies
    • Antidepressants or anti-anxiety medications
    • Blood pressure or diabetes medications

Short courses of oral steroids are especially known for causing temporary water retention and increased appetite, which can add weight quickly. Multiple bursts throughout the year can create a cumulative effect.

4. Changes after quitting smoking

Many people start regular inhaler therapy around the same time they try to reduce or quit smoking. This is a very positive step for long-term health, but it often comes with changes in appetite and metabolism.

Nicotine suppresses appetite and slightly increases metabolism, so removing it often leads to increased hunger and normalizes metabolism, making weight gain more likely.

According to a 2024 study, appetite also tends to increase during a smoking-cessation program. The biggest predictors of weight gain include:

    • Higher starting weight
    • Bigger drops in cotinine (greater nicotine reduction)
    • More time spent in the program (because quitting progressed)

If you recently quit or cut back, your weight gain may reflect that healthy transition rather than anything related to Symbicort.

5. Underlying medical or hormonal conditions

Some health conditions make weight more difficult to manage, such as:

    • Hypothyroidism
    • Polycystic ovary syndrome (PCOS)
    • Menopause-related hormone changes
    • Insulin resistance or type 2 diabetes
    • Cushing syndrome

These conditions often come to light only after someone notices ongoing weight changes and seeks testing. If your weight gain seems disproportionate or unexplained, your healthcare provider can order simple blood tests to rule out medical contributors.

How to tell if your weight gain is from Symbicort or something else

You usually cannot prove a single cause, but you can narrow down the likely contributors.

  • Look at the timeline Ask yourself,
      • What did my weight trend look like in the 6 to 12 months before starting Symbicort?
      • Did the weight start to rise only after starting the inhaler, or was it already increasing?
      • Did any major life changes happen around the same time, such as quitting smoking, a new job, pregnancy, a new medication, or reduced exercise?
  • Track weight and symptoms week by week For at least 8 to 12 weeks,
      • Record your weight once or twice per week at the same time of day.
      • Note any flare-ups that required oral steroids.
      • Log your daily activity, sleep, and major diet changes.
  • Review your complete medication list Bring a full list of prescription medicines, over-the-counter products, and supplements to your next appointment. Ask your doctor or pharmacist:
      • Which of these are known to affect weight, appetite, or water balance?
      • Whether any could interact with Symbicort to increase steroid exposure.
    Sometimes small medication adjustments can improve weight trends without sacrificing symptom control.
  • Consider alternative inhalers only when appropriate If you and your doctor suspect that high-dose budesonide is contributing to systemic steroid effects, a switch to another combination inhaler, a lower dose, or addition of a non-steroid controller might be reasonable. However, stopping or reducing ICS without a proper replacement can increase the risk of severe attacks. A pulmonary specialist or asthma clinic can help design a step-down plan that keeps you safe while testing whether a lower steroid burden improves your symptoms. Common inhaler combinations include:
      • Advair Diskus (fluticasone plus salmeterol)
      • Dulera (mometasone plus formoterol)
      • Breo Ellipta (fluticasone furoate plus vilanterol)
    Any change should be supervised by your clinician, with careful monitoring of symptoms and flare risk.
Symbicort Turbohaler

Starting from $145.95

Ready to Order Symbicort Turbohaler Online?

Choose Pharma Giant for affordable medications and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

PGSAVE10

When to talk to your doctor about weight gain on Symbicort

Consider contacting your clinician if:

    • You gain more than 5 to 10 pounds over a few months without a clear lifestyle explanation.
    • Your clothes become noticeably tighter around the waist or face.
    • You have weight gain plus new symptoms such as fatigue, weakness, or mood changes.

Seek prompt medical advice and urgent care if weight gain comes with:

    • Rapid swelling in the legs, abdomen, or around the eyes
    • Shortness of breath that worsens suddenly
    • Severe fatigue and low blood pressure
    • New stretch marks, easy bruising, or muscle weakness

These symptoms could point to heart problems, kidney issues, or significant adrenal and steroid-related disturbances that need specialist evaluation.

Bottom Line

Symbicort rarely causes noticeable short-term weight gain. Long-term medium or high doses of inhaled steroids may lead to small BMI increases in some people, especially women or those already overweight, but these effects are far less significant than with oral steroids.

If you’re concerned about weight changes, do not stop Symbicort suddenly, as this can trigger serious asthma or COPD flare-ups.

Instead, schedule a visit with your doctor. They can review your dose, consider alternatives if needed, and help you address weight concerns while keeping your lung disease safely controlled.

Related Articles

Frequently Asked Questions

Symbicort is not known to increase appetite in the same way that oral steroids do. Clinical trial summaries and patient information do not list increased appetite as a common side effect.

Mild stomach discomfort or bloating is possible but not very common. Symbicort itself is not strongly linked to fluid retention, but other factors, such as high salt intake, heart or kidney disease, and oral steroid use, can cause swelling. New or rapid swelling, especially with shortness of breath or chest pain, should be evaluated right away.

There is no strong evidence that standard Symbicort doses significantly slow metabolism in most people. High-dose inhaled steroids, in general, have been associated with metabolic effects, including increased diabetes risk, but this appears most relevant at higher doses and longer durations. Regular activity, a healthy diet, and good sleep remain the most important influences on metabolism for most patients.

Formoterol, the LABA in Symbicort, mainly affects the airways and sometimes the heart rate and nervous system. Common LABA side effects include tremor, palpitations, and nervousness, not weight gain. There is no strong evidence that LABAs alone change body weight in a meaningful way.

Some people may lose weight after starting Symbicort because their asthma or COPD comes under better control. With improved breathing, they move more, sleep better, and may make other healthy lifestyle changes. The medicine itself is not a weight loss drug, but better symptom control can indirectly support weight management.

Sources

Hedberg, A., & Rössner, S. (2000). Body weight characteristics of subjects on asthma medication. International Journal of Obesity, 24(9), 1217–1225. https://doi.org/10.1038/sj.ijo.0801382

Wangberg, H., Mortazavi, D., Kitsen, J., Sanni, A., Leibel, S., & Geng, B. (2022). Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma. Allergy and Asthma Proceedings, 43(5), 446–453. https://doi.org/10.2500/aap.2022.43.220027

Kunøe, A., Sevelsted, A., Chawes, B. L., Stokholm, J., Eliasen, A., Krakauer, M., Bønnelykke, K., & Bisgaard, H. (2021). Associations between Inhaled Corticosteroid Use in the First 6 Years of Life and Obesity-related Traits. American Journal of Respiratory and Critical Care Medicine, 204(6), 642–650. https://doi.org/10.1164/rccm.202009-3537oc

Rizk, A. K., Lavoie, K. L., Pepin, V., Wright, A., & Bacon, S. L. (2012). Sex Differences in the Effects of Inhaled Corticosteroids on Weight Gain among Patients with Asthma. ISRN Pulmonology, 2012, 1–7. https://doi.org/10.5402/2012/138326

Mohseni, M., Van Der Valk, E. S., Van Der Hurk, M. J. B., Savas, M., Boon, M. R., & Van Rossum, E. F. C. (2025). Corticosteroid Use and Long-Term Changes in Weight and Waist Circumference: The Lifelines Cohort Study. The Journal of Clinical Endocrinology & Metabolism, 110(12), e3989–e3997. https://doi.org/10.1210/clinem/dgaf166

Kakavas, S., & Karayiannis, D. (2025). Effects of Short-Term Exposure to High-Dose Inhaled Corticosteroids on Appetite, Dietary Intake, Leptin Levels, and Body Weight in Adults with Asthma—A Prospective Pilot Study. Journal of Personalized Medicine, 15(7), 326. https://doi.org/10.3390/jpm15070326

Lin, L., Song, Q., Duan, J., Liu, C., Cheng, W., Zhou, A., Peng, Y., Zhou, Z., Zeng, Y., Chen, Y., Cai, S., & Chen, P. (2023). The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease. Respiratory Research, 24(1), 98. https://doi.org/10.1186/s12931-023-02405-6

Chaput, J., Després, J., Bouchard, C., & Tremblay, A. (2008). The Association Between Sleep Duration and Weight Gain in Adults: A 6-Year Prospective Study from the Quebec Family Study. SLEEP, 31(4), 517–523. https://doi.org/10.1093/sleep/31.4.517

Krotter, A., García-Pérez, Á., Aonso-Diego, G., & García-Fernández, G. (2024). Body weight change during a smoking cessation intervention for individuals with overweight or obesity. Eating Behaviors, 53, 101882. https://doi.org/10.1016/j.eatbeh.2024.101882